Comparing dopaminergic dynamics in the dorsolateral striatum between adolescent and adult rats: Effect of an acute dose of WIN55212-2

Brain Res. 2019 Sep 15:1719:235-242. doi: 10.1016/j.brainres.2019.06.005. Epub 2019 Jun 7.

Abstract

During adolescence dopaminergic neurotransmission shows transient changes until reaching adulthood. The administration of CB1 agonists such as WIN55212-2 during adulthood increases dopamine extracellular levels. However, the effects of acute administration of cannabinoids on nigrostriatal dopamine neurotransmission during adolescence are not fully elucidated. The aim of this research is to compare dorsolateral striatum (DLS) dopamine (DA) dynamics and to study the effect of WIN55212-2 on DLS DA dynamics during adolescence and adulthood. No-net flux microdialysis experiments were carried out in adolescent (post-natal day 35-40) and young-adult (post-natal day 70-75) urethane-anesthetized rats. Basal DA dialysate, DA extraction fraction (Ed) and extracellular concentration of DA (Cext) in DLS were assessed after an acute injection of WIN55212-2 (1.2 mg/kg) or vehicle. An increased basal DA dialysate and DA Ed were observed during adolescence compared to adulthood. Moreover, WIN55212-2 increases DLS DA Cext rising basal DA dialysate in adulthood and decreasing DA Ed in adolescence. Our results suggest that an age-dependent mechanism underlies the effect of WIN 55212-2 on DA balance between release and uptake in DLS.

Keywords: Adolescence; Dopamine; Dorsolateral striatum; No-net flux microdialysis; WIN55212-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Benzoxazines / metabolism
  • Benzoxazines / pharmacology*
  • Cannabinoids / pharmacology
  • Corpus Striatum / drug effects*
  • Dopamine / metabolism*
  • Dopamine / pharmacology
  • Male
  • Morpholines / metabolism
  • Morpholines / pharmacology*
  • Naphthalenes / metabolism
  • Naphthalenes / pharmacology*
  • Neostriatum / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB1 / agonists
  • Receptor, Cannabinoid, CB1 / metabolism
  • Synaptic Transmission / drug effects

Substances

  • Benzoxazines
  • Cannabinoids
  • Cnr1 protein, rat
  • Morpholines
  • Naphthalenes
  • Receptor, Cannabinoid, CB1
  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
  • Dopamine